By Naomi Aoki, The Boston Globe Knight Ridder/Tribune Business News
Jun. 20--Boston Scientific Corp. said yesterday it filed its application with the U.S. Food and Drug Administration to market its drug-coated stent, putting the Natick medical device maker on track to be the second company behind Johnson & Johnson to bring the potentially lucrative new type of device to market.
The device, called the Taxus stent, props open clogged arteries and delivers the anticlogging drug paclitaxel to prevent them from narrowing again. Coated stents, considered a si